Similar articles

• Endothelium-specific overexpression of class III deacetylase SIRT1 decreases atherosclerosis in apolipoprotein E-deficient mice.

  Zhang QJ, Wang Z, Chen HZ, Zhou S, Zheng W, Liu G, Wei YS, Cai H, Liu DP, Liang CC. Zhang QJ, et al. Cardiovasc Res. 2008 Nov 1;80(2):191-9. doi: 10.1093/cvr/cvn224. Epub 2008 Aug 9. Cardiovasc Res. 2008. PMID: 18689793 Free PMC article.
• SIRT1: a novel target to prevent atherosclerosis.

  Yu W, Fu YC, Chen CJ, Wang X, Wang W. Yu W, et al. J Cell Biochem. 2009 Sep 1;108(1):10-3. doi: 10.1002/jcb.22240. J Cell Biochem. 2009. PMID: 19562740
• SIRT1 promotes endothelium-dependent vascular relaxation by activating endothelial nitric oxide synthase.

  Mattagajasingh I, Kim CS, Naqvi A, Yamamori T, Hoffman TA, Jung SB, DeRicco J, Kasuno K, Irani K. Mattagajasingh I, et al. Proc Natl Acad Sci U S A. 2007 Sep 11;104(37):14855-60. doi: 10.1073/pnas.0704329104. Epub 2007 Sep 4. Proc Natl Acad Sci U S A. 2007. PMID: 17785417 Free PMC article.
• Endothelium-Derived Nitric Oxide as an Antiatherogenic Mechanism: Implications for Therapy.

  Sukhovershin RA, Yepuri G, Ghebremariam YT. Sukhovershin RA, et al. Methodist Debakey Cardiovasc J. 2015 Jul-Sep;11(3):166-71. doi: 10.14797/mdcj-11-3-166. Methodist Debakey Cardiovasc J. 2015. PMID: 26634024 Free PMC article. Review.
• A breakthrough in diabetic nephropathy: the role of endothelial dysfunction.

  Nakagawa T, Segal M, Croker B, Johnson RJ. Nakagawa T, et al. Nephrol Dial Transplant. 2007 Oct;22(10):2775-7. doi: 10.1093/ndt/gfm380. Epub 2007 Jun 25. Nephrol Dial Transplant. 2007. PMID: 17595179 Review. No abstract available.